AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 107 filers reported holding AVIDITY BIOSCIENCES INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,582,693 | -39.3% | 248,071 | +5.5% | 0.00% | – |
| Q2 2023 | $2,608,767 | +18.1% | 235,236 | +63.5% | 0.00% | – |
| Q1 2023 | $2,208,404 | -28.1% | 143,870 | +3.9% | 0.00% | -100.0% |
| Q4 2022 | $3,071,296 | -5.1% | 138,409 | -30.2% | 0.00% | 0.0% |
| Q3 2022 | $3,238,000 | -79.1% | 198,293 | -81.4% | 0.00% | -66.7% |
| Q2 2022 | $15,521,000 | -26.0% | 1,068,223 | -5.9% | 0.00% | -25.0% |
| Q1 2022 | $20,977,000 | -13.8% | 1,135,744 | +10.9% | 0.00% | 0.0% |
| Q4 2021 | $24,333,000 | +62.2% | 1,023,720 | +68.0% | 0.00% | +33.3% |
| Q3 2021 | $15,006,000 | +29.9% | 609,263 | +30.3% | 0.00% | +50.0% |
| Q2 2021 | $11,552,000 | +67.6% | 467,456 | +47.9% | 0.00% | +100.0% |
| Q1 2021 | $6,892,000 | -50.1% | 316,011 | -41.6% | 0.00% | -66.7% |
| Q4 2020 | $13,816,000 | -34.4% | 541,415 | -27.6% | 0.00% | -25.0% |
| Q3 2020 | $21,059,000 | -14.8% | 748,107 | -14.5% | 0.00% | -33.3% |
| Q2 2020 | $24,729,000 | – | 875,088 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 849,651 | $13,042,143 | 13.77% |
| COWEN AND COMPANY, LLC | 4,592,966 | $70,502,028 | 8.28% |
| Cormorant Asset Management, LP | 2,612,115 | $40,096 | 2.64% |
| 5AM Venture Management, LLC | 665,555 | $10,216,269 | 2.61% |
| RA Capital Management | 6,416,998 | $98,500,919 | 2.23% |
| RTW INVESTMENTS, LP | 6,387,178 | $98,043,182 | 2.04% |
| COMMODORE CAPITAL LP | 590,705 | $9,067,322 | 1.38% |
| Casdin Capital, LLC | 850,000 | $13,047,500 | 1.08% |
| Boxer Capital, LLC | 1,121,327 | $17,212 | 0.85% |
| Octagon Capital Advisors LP | 382,000 | $5,863,700 | 0.84% |